Skip to main content
. 2020 Dec 21;21(1):39–64. doi: 10.1007/s40268-020-00329-w

Table 1.

Double-round Delphi results

Initial proposala First round proposalb Agreement after first roundb Second round proposalb Final agreementa
Number of drugsc 111 98 93 56 106
Continuous infusion 46 40 35 24 39
Intermittent infusion 71 62 62 32 71
Number of concentrations 221 205 82 81 183
Continuous infusion 109 102 24 41 (one new strength proposal) 67
Intermittent infusion 112 103 58 40 (three new strengths proposals) 116

Agreement for a definite concentration was achieved after the first round if it was selected by at least 70% of the panel members

Final agreement was achieved after the second round when concentrations with 40–69% votes were discussed

aReady-to-use drugs included (13 drugs; 16 different strengths)

bReady-to-use drugs excluded

cSome of the drugs are included in both continuous and intermittent infusions